A meta-analysis for headache in systemic lupus erythematosus: The evidence and the myth

Brain

Volumn 127, Issue 5, 2004, Pages 1200-1209

  Mitsikostas, Dimos D ^a,c   Sfikakis, Perros P ^b   Goadsby, Peter J ^c  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Headache; Migraine; Systemic lupus erythematosus

Indexed keywords

ANXIETY; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; HUMAN CELL; INTERNATIONAL COOPERATION; LUPUS HEADACHE; META ANALYSIS; MIGRAINE; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TENSION HEADACHE;

EID: 2442570098     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh146     Document Type: Review

References (62)

1. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001a; 57: 496-500.
2. Ainiala H, Hietaharju A, Loukkola J, Petrola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001b; 45: 419-23.
3. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353-65.
4. American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
5. Amit M, Molad Y, Levy O, Wysenbeek AJ. Headache in systemic lupus erythematosus and its relation to other disease manifestations. Clin Exp Rheumatol 1999; 17: 467-70.
6. Anzola GP, Dalla Volta G, Balestrieri G. Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings. Arch Neurol 1988; 45: 1061-2.
7. Appenzeller O. Return to the headache in systemic lupus erythematosus using modern technology. Cephalalgia 1998; 18: 171-2.
8. Atkinson RA, Appenzeller O. Headache in small vessel disease of the brain: a study of patients with systemic lupus erythematosus. Headache 1975; 15: 198-201.
9. Banecka-Majkutewicz Z. [Headache in systemic lupus erythematosus]. [Polish]. Neurol Neurochir Pol 1999; 32 Suppl 6: 149-55.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
11. Bosma GP, Rood, MJ, Zwinderman AH, Huizinga TW, van Buchem MA. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum 2000; 43: 48-54.
12. Bovim G, Jorstad S, Schrader H. Subdural hematoma presenting as headache in systemic lupus erythematosus. Cephalalgia 1990; 10: 25-9.
13. Brandt KD, Lessell S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 7-16.
14. Brey RL, Holliday SL, Saklad AR, Navarette MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized defintions. Neurology 2002; 58: 1214-20.
15. Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 2003; 12: 600-6.
16. Camilleri F, Mallia C. Male SLE patients in Malta. Adv Exp Med Biol 1999; 455: 173-9.
17. Cronin ME, Biswas RM, Van der Straeton C, Fleisher TA, Klippel JH. IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol 1988; 15: 795-8.
18. De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995; 35: 264-8.
19. Donders RC, Kappelle LJ, Derksen RH, Algra A, Horbach DA, de Groot PG, et al. Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology 1998; 51: 535-40.
20. Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998; 25: 675-80.
21. Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, et al. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache 1992; 32: 287-291.
22. Ferbert A, Busse D, and Thron A. Microinfarction in classic migraine? A study with magnetic resonance imaging findings. Stroke 1991; 22: 1010-4.
23. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, Abarca-Castalago M, De Haro-Liger M, Rodriguez-Andreu H, et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus 1999; 8: 151-6.
24. Galeazzi M, Annunziata P, Sebastiani GD, Bellisai F, Campanella V, Ferrara GB, et al. Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J Rheumatol 2000; 27: 135-41.
25. Glanz BI, Venkatesan A, Schur PH, Lew RA, Khoshbin S. Prevalence of migraine in patients with systemic lupus erythematosus. Headache 2001; 41: 285-9.
26. Goh R, Heritzen A, Tan CT, Hoh MC. Headaches and systemic lupus erythematosus: is there an entity of 'lupus headache'? Neurol J Southeast Asia 1997; 2: 51-6.
27. Gonzalez-Crespo MR, Blanco FJ, Ramos A, Ciruelo I, Mateo I, Lopez Pino MA, et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 1995; 34: 1055-60.
28. Haji Muhammad Ismail Hussain I, Loh WF, Sofiah A. Childhood cerebral lupus in an Oriental population. Brain Dev 1999; 21: 229-35.
29. Hietaharju A, Jantti V, Korpela M, Frey H. Nervous system involvement in systemic lupus erythematosus, Sjogren syndrome and scleroderma. Acta Neurol Scand 1993; 88: 299-308.
30. Hogan MJ, Brunet DG, Ford PM, Lillicrap D. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci 1988; 15: 420-5.
31. Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991; 11: 69-74.
32. Isenberg DA, Meyrick-Thomas D, Snaith ML, McKeran RO, Royston JP. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 30-2.
33. Lai NS, Lan JL. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 2000; 9: 353-7.
34. Laversuch CJ, Brown MM, Clifton A, Bourke BE. Cerebral venous thrombosis and acquired protein S deficiency: an uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol 1995; 34: 572-5.
35. Levine SR, Joseph R, D'Andrea G, Welch KM. Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia 1987; 7: 93-9.
36. Markus HS, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol 1992; 239: 39-42.
37. Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735-41.
38. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 766-71.
39. Montalban J, Cervera R, Font J, Ordi J, Vianna J, Haga HJ, et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology 1992; 42: 681-2.
40. Omdal R, Mellgren SI, Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol 1988; 17: 113-7.
41. Omdal R, Waterloo K, Koldingsnes W, Husby G, Mellgren SI. Somatic and psychological features of headache in systemic lupus erythematosus. J Rheumatol 2001; 28: 772-9.
42. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA, et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet 2001; 69: 447-53.
43. Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. AJNR Am J Neuroradiol 1991; 12: 521-4.
44. Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995; 13: 198-201.
45. Quintero-Del-Rio AI, Van Miller. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000; 15: 803-7.
46. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001; 21: 774-7.
47. Rood MJ, Breedveld FC, Huizinga TW. The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patients. Clin Exp Rheumatol 1999; 17: 55-61.
48. Rozell CL, Sibbitt WL Jr, Brooks WM. Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. Cephalalgia 1998; 18: 209-15.
49. Russell MB, Fenger K, and Olesen, J. The family history of migraine. Direct versus indirect information. Cephalalgia 1996; 16: 156-60.
50. Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol 1998; 37: 300-3.
51. Sibbitt WL Jr, Haseler LJ, Griffey RR, Freidman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997; 18: 1271-7.
52. Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29: 1536-42.
53. Steinlin MI, Blaser SI, Gilday DL, Eddy AA, Logan WJ, Laxer M, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995; 13: 191-7.
54. Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus 2001; 10: 51-8.
55. Terwindt GM, Haan J, Ophoff RA, Groenen SM, Storimans CW, Lanser JB, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998; 121: 303-16.
56. Tsakiris DA, Kappos L, Reber G, Marbet GA, Le Floch-Rohr J, Roux E, et al. Lack of association between antiphospholipid antibodies and migraine. Thromb Haemost 1993; 69: 415-7.
57. Vazquez-Cruz J, Traboulssi H, Rodriquez-De la Serna A, Geli C, Roig C, Diaz C. A prospective study of chronic or recurrent headache in systemic lupus erythematosus. Headache 1990; 30: 232-5.
58. Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990; 21: 1226-31.
59. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 527-39.
60. Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000; 59: 377-85.
61. Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D. Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol 1993; 32: 633-5.
62. Yuen SY, Lau KF, Steinberg AW, Grattan-Smith PJ, Hodson EM. Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus. J Paediatr Child Health 2001; 37: 405-8.